TCellR2Vec: efficient feature selection for TCR sequences for cancer classification
Related Experiment Video
Updated: May 3, 2026
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
Zahra Tayebi1, Sarwan Ali1, Murray Patterson1
1Computer Science, Georgia State University, Atlanta, GA, United States of America.
Abstract:
Cancer remains one of the leading causes of death globally. New immunotherapies that harness the patient's immune system to fight cancer show promise, but their development requires analyzing the diversity of immune cells called T-cells. T-cells have receptors that recognize and bind to cancer cells. Sequencing these T-cell receptors allows to provide insights into their immune response, but extracting useful information is challenging. In this study, we propose a new computational method, TCellR2Vec, to select key features from T-cell receptor sequences for classifying different cancer types. We extracted features like amino acid composition, charge, and diversity measures and combined them with other sequence embedding techniques. For our experiments, we used a dataset of over 50,000 T-cell receptor sequences from five cancer types, which showed that TCellR2Vec improved classification accuracy and efficiency over baseline methods. These results demonstrate TCellR2Vec's ability to capture informative aspects of complex T-cell receptor sequences. By improving computational analysis of the immune response, TCellR2Vec could aid the development of personalized immunotherapies tailored to each patient's T-cells. This has important implications for creating more effective cancer treatments based on the individual's immune system.
Insights
A new computational method, TCellR2Vec, effectively analyzes T-cell receptor sequences to classify cancer types. This advancement aids in developing personalized immunotherapies by improving the understanding of the immune response in cancer patients.
Area of Science:
- Computational Biology
- Immunology
- Oncology
Background:
- Cancer immunotherapy harnesses the patient's immune system to combat cancer.
- Analyzing T-cell receptor (TCR) sequence diversity is crucial for understanding immune responses in cancer.
- Extracting meaningful insights from complex TCR sequences presents a significant computational challenge.
Purpose of the Study:
- To develop a novel computational method, TCellR2Vec, for feature selection from TCR sequences.
- To enhance the classification accuracy and efficiency of different cancer types based on TCR sequence data.
- To improve the computational analysis of immune responses for personalized cancer therapy development.
Main Methods:
- TCellR2Vec was developed to extract key features from TCR sequences, including amino acid composition, charge, and diversity.
- Sequence embedding techniques were integrated with extracted features.
- A dataset of over 50,000 TCR sequences from five cancer types was utilized for experimental validation.
Main Results:
- TCellR2Vec demonstrated improved classification accuracy compared to baseline methods.
- The method showed enhanced efficiency in analyzing TCR sequence data.
- TCellR2Vec effectively captured informative aspects of complex TCR sequences.
Conclusions:
- TCellR2Vec offers a powerful computational tool for analyzing TCR sequences in cancer.
- The method has the potential to significantly aid in the development of personalized immunotherapies.
- Improved computational analysis of immune responses can lead to more effective, individualized cancer treatments.
